Nano-DSF Technology as a Preliminary Decision-Making Tool for Long Term Stability Evaluation of Covid-19 Vaccine Antigens

Rahul Misra, Siddhant Sharma, Manjit Haer, Jian Hu, Marina Kirkitadze, Przemek Kowal

Open source

DOI
10.1007/s11095-026-04097-1
Published
2026-04-23
Container
Pharmaceutical Research
Publisher
Springer Science and Business Media LLC
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1007/s11095-026-04097-1,
  title = {Nano-DSF Technology as a Preliminary Decision-Making Tool for Long Term Stability Evaluation of Covid-19 Vaccine Antigens},
  author = {Rahul Misra and Siddhant Sharma and Manjit Haer and Jian Hu and Marina Kirkitadze and Przemek Kowal},
  year = {2026},
  journal = {Pharmaceutical Research},
  doi = {10.1007/s11095-026-04097-1},
  url = {https://doi.org/10.1007/s11095-026-04097-1}
}

RIS

TY  - JOUR
TI  - Nano-DSF Technology as a Preliminary Decision-Making Tool for Long Term Stability Evaluation of Covid-19 Vaccine Antigens
AU  - Rahul Misra
AU  - Siddhant Sharma
AU  - Manjit Haer
AU  - Jian Hu
AU  - Marina Kirkitadze
AU  - Przemek Kowal
PY  - 2026
JO  - Pharmaceutical Research
DO  - 10.1007/s11095-026-04097-1
UR  - https://doi.org/10.1007/s11095-026-04097-1
ER  - 

APA

Misra, R., Sharma, S., Haer, M., Hu, J., Kirkitadze, M., & Kowal, P. (2026). Nano-DSF Technology as a Preliminary Decision-Making Tool for Long Term Stability Evaluation of Covid-19 Vaccine Antigens. Pharmaceutical Research. https://doi.org/10.1007/s11095-026-04097-1

Source records